Commercial Kit for screening for hereditary tyrosinemia type 1 (HT1)

A Contract Award Notice
by NHS ENGLAND

Source
Contracts Finder
Type
Contract (Services)
Duration
2 year
Value
£2M
Sector
HEALTH
Published
27 Aug 2025
Delivery
01 Apr 2025 to 31 Mar 2027
Deadline
31 Mar 2025 11:00

Concepts

Location

Geochart for 1 buyers and 1 suppliers

1 buyer

1 supplier

Description

Newborn Blood Spot screening (NBS) is a national programme offered to all babies born in the UK, and it currently screens for 9 rare but potentially lethal conditions. The blood spot screening sample is taken from the baby's heel collected on a filter paper dried blood spot (DBS) card. The blood sample is analysed by one of 13 newborn screening laboratories in England

Award Detail

1 Revvity (Rhondda Cynon Taff)
  • Value: £1,677,290

CPV Codes

  • 33696200 - Blood-testing reagents

Reference

Domains